Our facts clearly show that CK18 is consistently expressed in different epithelial cancers, In particular adenocarcinomas. the two loss of CK18 expression in cancers derived from CK18 optimistic precursor cells and neo-expression in malignancies derived from CK18 favourable precursors are usually linked to unfavorable tumor phenotype and disorder r